000 01287 a2200397 4500
005 20250518052345.0
264 0 _c20200305
008 202003s 0 0 eng d
022 _a1432-0711
024 7 _a10.1007/s00404-019-05254-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrunello, Jérémy
245 0 0 _aSafety considerations regarding Methotrexate off-label use in tubal ectopic pregnancy.
_h[electronic resource]
260 _bArchives of gynecology and obstetrics
_c10 2019
300 _a1095-1096 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMethotrexate
650 0 4 _aOff-Label Use
650 0 4 _aPregnancy
650 0 4 _aPregnancy, Ectopic
650 0 4 _aPregnancy, Tubal
650 0 4 _aProgesterone
650 0 4 _aTreatment Outcome
700 1 _aGuerby, Paul
700 1 _aCartoux, Chloé
700 1 _aYazigi, Alexandre
700 1 _aBaujat, Martin
700 1 _aParant, Olivier
700 1 _aVayssière, Christophe
700 1 _aChantalat, Elodie
700 1 _aVidal, Fabien
773 0 _tArchives of gynecology and obstetrics
_gvol. 300
_gno. 4
_gp. 1095-1096
856 4 0 _uhttps://doi.org/10.1007/s00404-019-05254-1
_zAvailable from publisher's website
999 _c29946884
_d29946884